Your browser doesn't support javascript.
loading
Understanding Long-Term Cancer Survivors' Preferences for Ongoing Medical Care.
Smith, Tenbroeck G; Strollo, Sara; Hu, Xin; Earle, Craig C; Leach, Corinne R; Nekhlyudov, Larissa.
Affiliation
  • Smith TG; Behavioral and Epidemiology Research Group, American Cancer Society, 250 Williams Street, Atlanta, GA, 30303, USA. tenbsmith@yahoo.com.
  • Strollo S; Behavioral and Epidemiology Research Group, American Cancer Society, 250 Williams Street, Atlanta, GA, 30303, USA.
  • Hu X; Yale Center for Analytical Sciences, Yale School of Public Health, New Haven, CT, USA.
  • Earle CC; Ontario Institute for Cancer Research, Toronto, Canada.
  • Leach CR; Behavioral and Epidemiology Research Group, American Cancer Society, 250 Williams Street, Atlanta, GA, 30303, USA.
  • Nekhlyudov L; Department of Medicine, Brigham & Women's Hospital, Boston, MA, USA.
J Gen Intern Med ; 34(10): 2091-2097, 2019 10.
Article in En | MEDLINE | ID: mdl-31367870
ABSTRACT

BACKGROUND:

Due to risk for treatment-related late effects and concerns about cancer recurrence, long-term cancer survivors have unique medical needs. Survivors' preferences for care may influence adherence and care utilization.

OBJECTIVE:

To describe survivors' preferences for care and factors associated with preferred and actual care.

DESIGN:

Cross-sectional analysis of participants in a longitudinal study using mailed questionnaires.

PARTICIPANTS:

Survivors of ten common cancers (n = 2,107, mean years from diagnosis 8.9). MAIN

MEASURES:

(1) Survivors' preferences for primary care physician (PCP) and oncologist responsibilities across four types of care cancer follow-up, cancer screening, preventive health, and comorbid conditions. (2) Survivor-reported visits to PCPs and oncologists. KEY

RESULTS:

The response rate was 42.1%. Most long-term survivors preferred PCPs and oncologists share care for cancer follow-up (63%) and subsequent screening (65%), while preferring PCP-led preventive health (77%) and comorbid condition (83%) care. Most survivors (88%) preferred oncologists involved in cancer follow-up care, but only 60% reported an oncologist visit in the previous 4 years, and 96% reported a PCP visit in the previous 4 years. In multivariable regressions, those with higher fear of cancer recurrence were less likely to prefer PCP-led cancer follow-up care (OR = 0.96, CI = 0.93-0.98), as did survivors with advanced cancer stage (OR = 0.56, CI = 0.39-0.79). Those with higher fear of recurrence (OR = 1.03, CI = 1.01-1.04) or who preferred oncologist-led cancer follow-up care (OR = 2.08, CI = 1.63-2.65) had greater odds of seeing an oncologist in the last 4 years.

CONCLUSIONS:

Most cancer survivors preferred PCPs and oncologists share care for cancer follow-up and screening, yet many had not seen an oncologist recently. Survivors preferred PCP-led care for other preventive services and management of comorbid conditions. These findings highlight the important role PCPs could play in survivor care, suggesting the need for PCP-oriented education and health system policies that support high-quality PCP-led survivor care.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aftercare / Patient Preference / Cancer Survivors Type of study: Observational_studies / Prevalence_studies / Qualitative_research / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Gen Intern Med Journal subject: MEDICINA INTERNA Year: 2019 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aftercare / Patient Preference / Cancer Survivors Type of study: Observational_studies / Prevalence_studies / Qualitative_research / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Gen Intern Med Journal subject: MEDICINA INTERNA Year: 2019 Type: Article Affiliation country: United States